Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma

OBJECTIVES: Endogenous hyperthyroidism accelerates bone turnover and shortens the normal bone remodeling cycle, which results in reduced bone density. It is estimated that suppressive levothyroxine (LT4) therapy also decreases bone density. The aim of this study was to define risk factors for osteop...

Descripción completa

Detalles Bibliográficos
Autores principales: Soydal, Çiğdem, Özkan, Elgin, Nak, Demet, Elhan, Atilla Halil, Küçük, Nuriye Özlem, Kır, Metin Kemal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592313/
https://www.ncbi.nlm.nih.gov/pubmed/31237137
http://dx.doi.org/10.4274/mirt.galenos.2019.89410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592313/
https://www.ncbi.nlm.nih.gov/pubmed/31237137
http://dx.doi.org/10.4274/mirt.galenos.2019.89410

Ejemplares similares